| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | President & CEO, Director | Common Stock | 655K | $11.7M | $17.84 | Dec 9, 2025 | Direct |
| Evommune, Inc. | President & CEO, Director | Employee Stock Option (Right to Buy) | 797K | Nov 5, 2025 | Direct | ||
| Evommune, Inc. | President & CEO, Director | Series Seed Preferred Stock | 0 | Nov 7, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | Dec 9, 2025 | 1 | -$502K | 4 | Dec 11, 2025 | President & CEO, Director |
| EVMN | Evommune, Inc. | Nov 7, 2025 | 2 | $0 | 4 | Nov 12, 2025 | President & CEO, Director |
| EVMN | Evommune, Inc. | Nov 5, 2025 | 1 | $0 | 4 | Nov 7, 2025 | President & CEO, Director |
| EVMN | Evommune, Inc. | Nov 5, 2025 | 0 | $0 | 3 | Nov 5, 2025 | President & CEO, Director |